(Reuters) -CVS Health added Glenview Capital's top boss and three others to its board in a deal with the hedge fund, a month after the healthcare conglomerate tasked a new CEO with its turnaround ...

Hedge fund Glenview Capital Management is set to meet with top executives at CVS Health on Monday to propose operational improvements, The Wall Street Journal reported, citing people with ...

NEW YORK, May 6, 2025 /PRNewswire/ -- One year ago, we established a concentrated position in shares of CVS Health (NYSE: CVS). Since our purchases in May 2024, CVS shares have generated a total ...

CVS Health announced on Monday that it struck a deal with dissident investor Glenview Capital for four board seats, just a few weeks after the health-care giant ousted former CEO Karen Lynch.

Sept 29 (Reuters) - Healthcare-focused Glenview Capital Management will meet top executives at struggling healthcare company CVS Health (CVS.N) on Monday to propose ways it can improve operations ...

Longtime investor Glenview Capital Management bought 2.8 million CVS shares during the third quarter, increasing its stake by 31%. The firm owned 0.95% of the company on Sept. 30, the filing shows.

Glenview Capital Management will meet with top CVS executives to exchange ideas on how to make improvements at the healthcare company, according to a report from The Wall Street Journal.

NEW YORK, Oct. 18, 2024 /PRNewswire/ -- Earlier, Glenview and CVS executed a Non-Disclosure Agreement to facilitate the good faith exchange of information and perspectives and discussions commenced.

CVS Health announced on Monday that it struck a deal with dissident investor Glenview Capital for four board seats, just a few weeks after the health-care giant ousted former CEO Karen Lynch.